AOD 9604

The Most Advanced Lipolytic Research Peptide for Targeted Fat ReductionAOD9604 is a modified fragment of human growth hormone (hGH 177-191) specifically engineered to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage) — without affecting growth, IGF-1 levels, or insulin sensitivity.Originally developed as an anti-obesity drug, AOD9604 has gained massive popularity in research and body-recomposition circles for its ability to trigger significant fat loss, especially in stubborn abdominal and visceral areas, while offering an outstanding safety profile compared to full-length growth hormone.Key Benefits of AOD9604

• Accelerates fat loss from stubborn areas

• Promotes lipolysis while blocking new fat formation

• No impact on blood sugar or insulin resistance

• Does not raise IGF-1 or cause growth-related side effects

• Supports cartilage regeneration and joint health

• Extremely well-tolerated in human clinical trials

• Available for research in both injectable and oral forms

How AOD9604 Works

AOD9604 mimics only the fat-regulating portion of the hGH molecule. It binds directly to fat-cell receptors, activating hormone-sensitive lipase (HSL) to break down stored triglycerides into free fatty acids for energy — delivering powerful, targeted fat reduction when combined with proper diet and training.Common Research Applications

• Obesity and metabolic syndrome studies

• Body recomposition and contest preparation

• Preserving lean mass during calorie deficits

• Joint and connective-tissue regeneration research

AOD9604 – pure fat-loss precision without the risks.